Business Development Manager at Xiamen Spacegen.Co.,Ltd - Xiamen Shi, Fujian Sheng, China
Xiamen SpaceGen® Co.,Ltd., integrating R & D, production, sales and advisory services, is dedicated to providing the most innovative products and services for cancer, genetic diseases and other personalized precision medical testing. We provide the total solution products for early screening, disease diagnosis, individual drug selection and efficacy monitoring.Spacegen® Covers an area of 3000 m2 GMP-compliant manufacturing plant, 1000 m2 R&D/QC lab,and is equipped with high-throughput sequencing platform, fluorescence quantitative PCR platform and generation of sequencing platform. Based on Next generation sequencing, Real Time PCR and other technology platforms, SpaceGen® has developed a number of individualized medical products. Library kit for Gene sequencing has obtained the Class I Medical Device Certificate;Human Oncology Multi-Gene Mutations Detection Kit,Human BRCA1/2 Gene Mutations Detection Kit,Human EGFR Gene Mutations Detection Kit ,Human K-ras Gene Mutations Detection Kit,Human BRAF Gene Mutations Detection Kit have obtained the international EU CE-IVD certification.Spacegen® have developed patent technologies including RingCap® (Ring-Link Capture Library technology) and PAP-ARMS® (pyrophosphorolysis-activated polymerization amplification refractory mutation system) RingCap® advanteges:(1) takes two steps sampling, two steps purification;(2)From sample to library only needs 3.5 hours; (3) Be both suitable for illumina and ion torrent platforms. PAP-ARMS ® Technical Vantages: (1). With very strong specificity, it can achieve the detection of single-digit copy number mutation, and increase the sensitivity to 0.1%; (2) Easy and fast to operate, it can be can be used in the ordinary fluorescence quantitative PCR platform.